Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Kateřina Veverová"'
Autor:
Vanesa Jurasova, Ross Andel, Alzbeta Katonova, Katerina Veverova, Terezie Zuntychova, Hana Horakova, Martin Vyhnalek, Tereza Kolarova, Vaclav Matoska, Kaj Blennow, Jakub Hort
Publikováno v:
Alzheimer’s Research & Therapy, Vol 16, Iss 1, Pp 1-15 (2024)
Abstract Background There is initial evidence suggesting that biomarker neurogranin (Ng) may distinguish Alzheimer’s disease (AD) from other neurodegenerative diseases. Therefore, we assessed (a) the discriminant ability of cerebrospinal fluid (CSF
Externí odkaz:
https://doaj.org/article/886e4ceace9042c0a59b388df743aca1
Autor:
Veronika Matuskova, Katerina Veverova, Dylan J. Jester, Vaclav Matoska, Zahinoor Ismail, Katerina Sheardova, Hana Horakova, Jiri Cerman, Jan Laczó, Ross Andel, Jakub Hort, Martin Vyhnalek
Publikováno v:
Alzheimer’s Research & Therapy, Vol 16, Iss 1, Pp 1-11 (2024)
Abstract Background Mild behavioral impairment (MBI) has been commonly reported in early Alzheimer’s disease (AD) but rarely using biomarker-defined samples. It is also unclear whether genetic polymorphisms influence MBI in such individuals. We thu
Externí odkaz:
https://doaj.org/article/0d78f2fc6134470294c48483872cec2f
Autor:
Domenica Caponio, Kateřina Veverová, Shi-qi Zhang, Liu Shi, Garry Wong, Martin Vyhnalek, Evandro F. Fang
Publikováno v:
Aging Brain, Vol 2, Iss , Pp 100056- (2022)
Alzheimer’s disease (AD) is one of the most persistent and devastating neurodegenerative disorders of old age, and is characterized clinically by an insidious onset and a gradual, progressive deterioration of cognitive abilities, ranging from loss
Externí odkaz:
https://doaj.org/article/b0c571f4477647729b131173e5c34ca1
Publikováno v:
ACS Omega, Vol 8, Iss 39, Pp 36025-36031 (2023)
Externí odkaz:
https://doaj.org/article/d80711c809c14ada851ffa51abe50f95
Autor:
Monica E. Nelson, Britney M. Veal, Ross Andel, Julie Martinkova, Katerina Veverova, Hana Horakova, Zuzana Nedelska, Jan Laczó, Martin Vyhnalek, Jakub Hort
Publikováno v:
Frontiers in Aging Neuroscience, Vol 14 (2022)
BackgroundDementia syndrome is one of the most devastating conditions in older adults. As treatments to stop neurodegeneration become available, accurate and timely diagnosis will increase in importance. One issue is that cognitive performance someti
Externí odkaz:
https://doaj.org/article/f9146ad75d4849128f44f7bbf8528b70
Autor:
Francesco Angelucci, Katerina Veverova, Alžbeta Katonová, Lydia Piendel, Martin Vyhnalek, Jakub Hort
Publikováno v:
Pharmaceuticals, Vol 15, Iss 9, p 1074 (2022)
Alzheimer’s disease (AD) is a central nervous system (CNS) disease characterized by loss of memory, cognitive functions, and neurodegeneration. Plasmin is an enzyme degrading many plasma proteins. In the CNS, plasmin may reduce the accumulation of
Externí odkaz:
https://doaj.org/article/10736cb731c94ecca32a1f16d7b7938f